Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Disposition to Issuer of 42,137 TBPH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Theravance Biopharma, Inc. (TBPH) | Disposition to Issuer | 42,137 | n/a |
| Jun 18, 2026 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 50,000 | n/a |
| Jun 17, 2026 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 6,009 | n/a |
| May 28, 2026 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/Award | 46,293 | n/a |
| Apr 29, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 11,250 | n/a |
| Jun 20, 2025 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/Award | 22,500 | n/a |
| Jun 18, 2025 | MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | Grant/Award | 89,139 | $192.5K |
| May 21, 2025 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 10,649 | n/a |
| Aug 20, 2024 | Morphic Holding, Inc. (MORF) | Disposition to Issuer | 18,111 | n/a |
| Jun 5, 2024 | Morphic Holding, Inc. (MORF) | Grant/Award | 23,168 | n/a |